• 7504 Citations
  • 47 h-Index
19962018
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 18 Similar Profiles
T-Lymphocytes Medicine & Life Sciences
T-cells Chemical Compounds
Cytotoxic T-Lymphocytes Medicine & Life Sciences
Antigen Receptors Medicine & Life Sciences
Human Herpesvirus 4 Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Transplants Medicine & Life Sciences
T-Cell Antigen Receptor Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1996 2018

CD30-redirected chimeric antigen receptor T cells target CD30+ and CD30- embryonal carcinoma via antigen-dependent and fas/fasl interactions

Hong, L. K., Chen, Y., Smith, C. C., Montgomery, S. A., Vincent, B. G., Dotti, G. & Savoldo, B., Oct 1 2018, In : Cancer Immunology Research. 6, 10, p. 1274-1287 14 p.

Research output: Contribution to journalArticle

Embryonal Carcinoma
CD95 Antigens
T-Cell Antigen Receptor
Embryonal Carcinoma Stem Cells
Antigen Receptors
4 Citations

Constitutive and TNFα-inducible expression of chondroitin sulfate proteoglycan 4 in glioblastoma and neurospheres: Implications for CAR-T cell therapy

Pellegatta, S., Savoldo, B., Di Ianni, N., Corbetta, C., Chen, Y., Patané, M., Sun, C., Pollo, B., Ferrone, S., DiMeco, F., Finocchiaro, G. & Dotti, G., Feb 28 2018, In : Science Translational Medicine. 10, 430, eaao2731.

Research output: Contribution to journalArticle

Antigen Receptors
Glioblastoma
Cell- and Tissue-Based Therapy
Neoplasms
Tumor Escape

In Vivo Fate and Activity of Second- versus Third-Generation CD19-Specific CAR-T Cells in B Cell Non-Hodgkin's Lymphomas

Ramos, C. A., Rouce, R., Robertson, C. S., Reyna, A., Narala, N., Vyas, G., Mehta, B., Zhang, H., Dakhova, O., Carrum, G., Kamble, R. T., Gee, A. P., Mei, Z., Wu, M. F., Liu, H., Grilley, B., Rooney, C. M., Heslop, H. E., Brenner, M. K., Savoldo, B. & 1 othersDotti, G., Dec 5 2018, In : Molecular Therapy. 26, 12, p. 2727-2737 11 p.

Research output: Contribution to journalArticle

B-Cell Lymphoma
Antigen Receptors
Non-Hodgkin's Lymphoma
T-Lymphocytes
B-Lymphocytes
3 Citations

Treating hematological malignancies with cell therapy: where are we now?

Landoni, E. & Savoldo, B., Jan 2 2018, In : Expert Opinion on Biological Therapy. 18, 1, p. 65-75 11 p.

Research output: Contribution to journalReview article

CD19 Antigens
CD3 Antigens
Recombinant Fusion Proteins
Hematologic Neoplasms
Cell- and Tissue-Based Therapy
36 Citations

CAR T Cells Administered in Combination with Lymphodepletion and PD-1 Inhibition to Patients with Neuroblastoma

Heczey, A., Louis, C. U., Savoldo, B., Dakhova, O., Durett, A., Grilley, B., Liu, H., Wu, M. F., Mei, Z., Gee, A., Mehta, B., Zhang, H., Mahmood, N., Tashiro, H., Heslop, H. E., Dotti, G., Rooney, C. M. & Brenner, M. K., Sep 6 2017, In : Molecular Therapy. 25, 9, p. 2214-2224 11 p.

Research output: Contribution to journalArticle

T-Cell Antigen Receptor
Neuroblastoma
Cyclophosphamide
Antigen Receptors
T-Lymphocytes